Literature DB >> 3444372

Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion.

W J van Blitterswijk1, H Hilkmann, G A Storme.   

Abstract

Tumor cells grown in the presence of 1-O-alkyl-2-O-methylglycero-3-phosphocholine (AMG-PC) accumulated this ether lipid in their membranes. Depending on the cell type and the dose of the compound, up to 17% of the total phospholipids of the purified plasma membranes consisted of authentic AMG-PC. Extensive incorporation of the agent resulted in a decrease in plasma membrane fluidity and inhibition of tumor cell invasiveness in embryonic chick heart fragments. The extent of AMG-PC incorporation and fluidity change was not strictly correlated with the degree to which tumor cell invasion was inhibited.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3444372     DOI: 10.1007/BF02535537

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  15 in total

1.  A FAST, SIMPLE AND RELIABLE METHOD FOR THE MICRODETERMINATION OF PHOSPHORUS IN BIOLOGICAL MATERIALS.

Authors:  W R MORRISON
Journal:  Anal Biochem       Date:  1964-02       Impact factor: 3.365

2.  Tumor- and growth-related membrane changes caused by transformation with different fragments of the adenovirus 12 genome.

Authors:  L de Leij; L A Smets; H Jochemsen; A J van der Eb
Journal:  Virology       Date:  1982-10-15       Impact factor: 3.616

3.  Methods of study of the invasion of malignant C3H-mouse fibroblasts into embryonic chick heart in vitro.

Authors:  M Mareel; J Kint; C Meyvisch
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1979-05-04

4.  Metastatic heterogeneity of cells from Lewis lung carcinoma.

Authors:  A L van Lamsweerde; N Henry; G Vaes
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

5.  Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements.

Authors:  W J Van Blitterswijk; R P Van Hoeven; B W Van der Meer
Journal:  Biochim Biophys Acta       Date:  1981-06-22

6.  (+)-Catechin inhibits the invasion of malignant fibrosarcoma cells into chick heart in vitro.

Authors:  M E Bracke; R M Van Cauwenberge; M M Mareel
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

7.  Differences in membrane lipid composition and fluidity of transplanted GRSL lymphoma cells, depending on their site of growth in the mouse.

Authors:  W J Van Blitterswijk; H Hilkmann; T Hengeveld
Journal:  Biochim Biophys Acta       Date:  1984-12-19

8.  A metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C.

Authors:  W J van Blitterswijk; R L van der Bend; I M Kramer; A J Verhoeven; H Hilkmann; J de Widt
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

9.  Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.

Authors:  G A Storme; W E Berdel; W J van Blitterswijk; E A Bruyneel; G K De Bruyne; M M Mareel
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

10.  Influence of implantation site of MO4 cell aggregates on the formation of metastases.

Authors:  C Meyvisch; M Mareel
Journal:  Invasion Metastasis       Date:  1982
View more
  17 in total

1.  Intestinal absorption of miltefosine: contribution of passive paracellular transport.

Authors:  Cécile Ménez; Marion Buyse; Christophe Dugave; Robert Farinotti; Gillian Barratt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

2.  Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid rafts.

Authors:  Arnold H Van der Luit; Marianne Budde; Shuraila Zerp; Wendy Caan; Jeffrey B Klarenbeek; Marcel Verheij; Wim J Van Blitterswijk
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

3.  Synthesis and biological evaluation of ether-linked derivatives of phosphatidylinositol.

Authors:  K S Ishaq; M Capobianco; C Piantadosi; A Noseda; L W Daniel; E J Modest
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

4.  Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro.

Authors:  Cécile Ménez; Marion Buyse; Madeleine Besnard; Robert Farinotti; Philippe M Loiseau; Gillian Barratt
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

5.  Growth inhibitory effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.

Authors:  A C Peters; I Ahmad; A S Janoff; M Y Pushkareva; E Mayhew
Journal:  Lipids       Date:  1997-10       Impact factor: 1.880

6.  The effect of culture medium composition on ether lipid cytotoxic activity.

Authors:  L Diomede; B Piovani; E J Modest; M Salmona
Journal:  Lipids       Date:  1993-03       Impact factor: 1.880

7.  Effect of cell density on cytotoxicity of ether lipid analogues in variants of B16 murine melanoma.

Authors:  L L Trulla; A Magistrelli; M Salmona; M T Tacconi
Journal:  Lipids       Date:  1993-05       Impact factor: 1.880

8.  Inward translocation of the phospholipid analogue miltefosine across Caco-2 cell membranes exhibits characteristics of a carrier-mediated process.

Authors:  Cécile Ménez; Marion Buyse; Robert Farinotti; Gillian Barratt
Journal:  Lipids       Date:  2007-02-06       Impact factor: 1.880

9.  A metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C.

Authors:  W J van Blitterswijk; R L van der Bend; I M Kramer; A J Verhoeven; H Hilkmann; J de Widt
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

10.  Molecular species of glycerophospholipids and sphingomyelins of human erythrocytes: improved method of analysis.

Authors:  J J Myher; A Kuksis; S Pind
Journal:  Lipids       Date:  1989-05       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.